Use of the amplified Mycobacterium tuberculosis direct test in a public health laboratory -: Test performance and impact on clinical care

被引:41
作者
Guerra, Renata L.
Hooper, Nancy M.
Baker, James F.
Alborz, Roya
Armstrong, Derek T.
Maltas, Gina
Kiehlbauch, Julia A.
Dorman, Susan E.
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21231 USA
[2] Maryland Dept Hlth & Mental Hyg, Baltimore, MD 21201 USA
关键词
Mycobacterium tuberculosis direct test; diagnosis; respiratory specimens; tuberculosis; amplified;
D O I
10.1378/chest.06-2959
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: The Amplified Mycobacterium tuberculosis Direct Test (MTD; Gen-Probe; San Diego, CA) is a nucleic-acid amplification test for rapid pulmonary tuberculosis (PTB) diagnosis. In a routine public health setting, test accuracy and impact on clinical decisions are unknown. Methods: Retrospectively, we evaluated MTD accuracy and impact on clinical decisions in a public health setting. To estimate MTD accuracy, mycobacterial culture was used as the "gold standard." To evaluate MTD impact on clinical decisions, concordance of clinician presumptive diagnosis (at time of MTD and smear availability) and definitive diagnosis, and duration of nonindicated tuberculosis therapy were determined for smear-positive PTB suspects in a period of MTD availability (MTD group) and a prior period of MTD nonavailability (non-MTD group). Results: A total of 1,151 respiratory specimens from 638 PTB suspects were analyzed. MTD sensitivity, specificity, positive predictive value, and negative predictive value were 91.7%, 98.7%, 96.7%, and 96.5% overall, respectively; and 98.7%, 97.8%, 98.7%, and 97.8% for smear-positive patients; and 62.2%, 98.9%, 85.2%, and 96.1% for smear-negative patients. In the MTD group, concordance between definitive and clinician presumptive diagnoses was 78% (95% confidence interval [CI], 64 to 88%), similar to that for the non-MTD group (79%; 95% CI, 68.4 to 89.6%). However, concordance between definitive diagnosis and the MTD test was 98% (95% CL 94.1 to 100%). Median duration of nonindicated tuberculosis treatment was 6 days for the MTD group vs 31 days for the non-MTD group (p = 0.002). Conclusion: In this public health setting, MTD was accurate and rapidly detected more than half of the smear-negative PTB cases. For smear-positive PTB suspects, MTD had excellent concordance with definitive diagnosis, but clinicians often inappropriately initiated TB therapy despite a negative MTD result.
引用
收藏
页码:946 / 951
页数:6
相关论文
共 15 条
[1]   Clinical evaluation of the enhanced gen-probe amplified mycobacterium tuberculosis direct test for rapid diagnosis of tuberculosis in prison inmates [J].
Bergmann, JS ;
Yuoh, G ;
Fish, G ;
Woods, GL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (05) :1419-1425
[2]   The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis - Results of a multicenter prospective trial [J].
Catanzaro, A ;
Perry, S ;
Clarridge, JE ;
Dunbar, S ;
Goodnight-White, S ;
LoBue, PA ;
Peter, C ;
Pfyffer, GE ;
Sierra, MF ;
Weber, R ;
Woods, G ;
Mathews, G ;
Jonas, V ;
Smith, K ;
Della-Latta, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (05) :639-645
[3]  
Catanzaro A, 1997, AM J RESP CRIT CARE, V155, P1804, DOI 10.1164/ajrccm.155.5.9154896
[4]  
Coll P, 2003, INT J TUBERC LUNG D, V7, P886
[5]   Comparative evaluation of initial and new versions of the Gen-Probe amplified Mycobacterium Tuberculosis Direct Test for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens [J].
Gamboa, F ;
Fernandez, G ;
Padilla, E ;
Manterola, JM ;
Lonca, J ;
Cardona, PJ ;
Matas, L ;
Ausina, V .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (03) :684-689
[6]  
Kent P.T., 1985, PUBLIC HLTH MYCOBACT
[7]   Role of clinical judgment application of a nucleic amplification test for the rapid diagnosis of pulmonary tuberculosis [J].
Lim, TK ;
Mukhopadhyay, A ;
Gough, A ;
Khoo, KL ;
Khoo, SM ;
Lee, KH ;
Kumarasinghe, G .
CHEST, 2003, 124 (03) :902-908
[8]   Epidemiology of human pulmonary infection with nontuberculous mycobacteria [J].
Marras, TK ;
Daley, CL .
CLINICS IN CHEST MEDICINE, 2002, 23 (03) :553-+
[9]  
Murray P.R., 1999, MANUAL CLIN MICROBIO, V7th
[10]   Practical strategies for performance optimization of the enhanced Gen-Probe Amplified Mycobacterium Tuberculosis Direct test [J].
Sloutsky, A ;
Han, LL ;
Werner, BG .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (04) :1547-1551